发明名称 |
METHOD FOR REDUCING AMYLOID DEPOSITION, AMYLOID NEUROTOXICITY, AND MICROGLIOSIS WITH (-)-NILVADIPINE ENANTIOMER |
摘要 |
<p>The present invention provides methods for reducing Aβdeposition, Aβneurotoxicity and microgliosis in an animal or human afflicted with a cerebral amyloidogenic disease, such as Alzheimer's disease (AD), by administering therapeutically effective amounts of the (R)-enantiomer of the dihydropyridine compound nilvadipine, also known as (−)-nilvadipine, to the animal or human. Further provided are methods for reducing the risk of Aβdeposition, Aβneurotoxicity and microgliosis in animals or humans suffering from traumatic brain injury by administering (−)-nilvadipine after the traumatic brain injury and continuing treatment for a prescribed period of time thereafter.</p> |
申请公布号 |
EP2214666(B1) |
申请公布日期 |
2013.12.11 |
申请号 |
EP20080836256 |
申请日期 |
2008.10.03 |
申请人 |
ALZHEIMER'S INSTITUTE OF AMERICA, INC. |
发明人 |
MULLAN, MICHAEL, J.;PARIS, DANIEL;IVEY, ROBERT, A., III |
分类号 |
A61K31/4422;A61K31/44;A61P25/28 |
主分类号 |
A61K31/4422 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|